Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 500 results in range #101 to #600.
View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)
- ICRP Publication 150 (1 revision)
- ICRP Publication 25 (1 revision)
- ICRP Publication 26 (1 revision)
- DS86 (1 revision)
- Relative life lost (1 revision)
- ICRP Publication 32 (1 revision)
- ICRP Publication 99 (1 revision)
- ICRP Publication 47 (1 revision)
- Security screening (1 revision)
- ICRP Publication 61 (1 revision)
- ICRP Publication 76 (1 revision)
- Stochastic effect (1 revision)
- Equilibrium equivalent concentration (1 revision)
- Expanded radiation field (1 revision)
- 1937 Recommendations (1 revision)
- Tolerance dose (1 revision)
- Adventitious source (1 revision)
- Occupancy factor (1 revision)
- Annual intake (1 revision)
- ICRP Publication 109 (1 revision)
- ICRP Publication 122 (1 revision)
- ICRP Publication 137 (1 revision)
- Radon-prone area (1 revision)
- ICRP Publication 151 (1 revision)
- Reference Person (1 revision)
- ICRP Publication 27 (1 revision)
- Relative risk (1 revision)
- ICRP Publication 33 (1 revision)
- Detriment-adjusted risk (1 revision)
- Ring chromosome (1 revision)
- ICRP Supporting Guidance 2 (1 revision)
- ICRP Publication 48 (1 revision)
- Dose-response function (1 revision)
- ICRP Publication 62 (1 revision)
- International Commission on Radiological Protection (1 revision)
- ICRP Publication 77 (1 revision)
- Lag (1 revision)
- Equilibrium factor (1 revision)
- Teratocarcinoma (1 revision)
- Low dose (1 revision)
- 1950 Recommendations (1 revision)
- Backscatter factor (1 revision)
- Potentially lethal damage repair (1 revision)
- ICRP Publication 10A (1 revision)
- ICRP Publication 123 (1 revision)
- Charged-particle equilibrium (1 revision)
- ICRP Publication 138 (1 revision)
- Collimation (1 revision)
- ICRP Publication 152 (1 revision)
- ICRP Publication 28 (1 revision)
- Relative survival (1 revision)
- ICRP Publication 34 (1 revision)
- ICRP Publication 49 (1 revision)
- ICRP Publication 63 (1 revision)
- Source region (1 revision)
- ICRP Publication 78 (1 revision)
- Elemental dose (1 revision)
- Late normal tissue responses (1 revision)
- Exposed individuals (1 revision)
- 1954 Recommendations (1 revision)
- Α/β value (1 revision)
- Oncogene (1 revision)
- Apoptosis (1 revision)
- ICRP Publication 11 (1 revision)
- ICRP Publication 124 (1 revision)
- ICRP Publication 139 (1 revision)
- ICRP Publication 153 (1 revision)
- ICRP Publication 29 (1 revision)
- ICRP Publication 35 (1 revision)
- ICRP Publication 5 (1 revision)
- Dose-threshold hypothesis (1 revision)
- Severe deterministic injury (1 revision)
- ICRP Publication 64 (1 revision)
- Intervention (1 revision)
- ICRP Publication 79 (1 revision)
- Sublethal damage repair (1 revision)
- 1956 Recommendations (1 revision)
- Transfer of risk (1 revision)
- Molecular imaging (1 revision)
- Activation (1 revision)
- Noise (1 revision)
- ΓH2AX foci (1 revision)
- Operating management (1 revision)
- Pencil beam (1 revision)
- ICRP Publication 1 (1 revision)
- Baseline disease rates (1 revision)
- Practice (1 revision)
- ICRP Publication 110 (1 revision)
- Breakpoint cluster region/abelson (1 revision)
- ICRP Publication 125 (1 revision)
- ICRP Publication 14 (1 revision)
- Commissioning (1 revision)
- ICRP Publication 154 (1 revision)
- Cosmic radiation (1 revision)
- ICRP Publication 3 (1 revision)
- ICRP Publication 36 (1 revision)
- Dicentric chromosome (1 revision)
- Risk model (1 revision)
- ICRP Publication 50 (1 revision)
- Dose and dose-rate effectiveness factor (1 revision)
- Sheltering (1 revision)
- Induced genomic instability (1 revision)
- ICRP Publication 65 (1 revision)
- ICRP Publication 8 (1 revision)
- Licensee (1 revision)
- Thermodynamic diameter (1 revision)
- Low linear energy transfer radiation (1 revision)
- 1959 Decisions (1 revision)
- Nominal risk coefficient (1 revision)
- Hereditary effect (1 revision)
- ICRP Publication 10 (1 revision)
- ICRP Publication 111 (1 revision)
- Quality control testing (1 revision)
- ICRP Publication 126 (1 revision)
- Radioactive waste (1 revision)
- ICRP Publication 140 (1 revision)
- ICRP Publication 155 (1 revision)
- ICRP Publication 30 (1 revision)
- Dental and maxillofacial imaging (1 revision)
- ICRP Publication 37 (1 revision)
- ICRPædia Guide to Radiological Protection in Healthcare (1 revision - redirect page)
- ICRP Publication 51 (1 revision)
- Shielding (1 revision)
- ICRP Publication 66 (1 revision)
- ICRP Publication 80 (1 revision)
- Superposition principle (1 revision)
- Life Span Study (1 revision)
- Thoracic airways (1 revision)
- Multifactorial diseases (1 revision)
- Active detection system (1 revision)
- Nominal value (1 revision)
- ICRP Publication 100 (1 revision)
- ICRP Publication 112 (1 revision)
- ICRP Publication 127 (1 revision)
- ICRP Publication 141 (1 revision)
- ICRP Publication 16 (1 revision)
- ICRP Publication 30 (Index) (1 revision)
- ICRP Publication 38 (1 revision)
- ICRP Publication 52 (1 revision)
- Dose commitment (1 revision)
- ICRP Publication 67 (1 revision)
- Doubling dose (1 revision)
- ICRP Publication 81 (1 revision)
- Supervised area (1 revision)
- Evacuation (1 revision)
- Thoron progeny (1 revision)
- Exposure index (1 revision)
- AML/eto (1 revision)
- Transgenerational effect (1 revision)
- Frequent flyer (1 revision)
- Non-homologous end joining (1 revision)
- Optimisation of protection (1 revision)
- Attributable risk (1 revision)
- ICRP Publication 101 (1 revision)
- Best available techniques (1 revision)
- ICRP Publication 113 (1 revision)
- Bronchiolar region (1 revision)
- Quasi-threshold dose (1 revision)
- ICRP Publication 128 (1 revision)
- ICRP Publication 142 (1 revision)
- Compartment (1 revision)
- Radon progeny (1 revision)
- ICRP Publication 17 (1 revision)
- Count median diameter (1 revision)
- Reference parameter value (1 revision)
- ICRP Publication 30 (Part 1) (1 revision)
- Deposition (1 revision)
- ICRP Publication 90 (1 revision)
- ICRP Publication 39 (1 revision)
- Digital breast tomosynthesis (1 revision)
- ICRP Publication 53 (1 revision)
- Size-specific dose estimate (1 revision)
- ICRP Publication 68 (1 revision)
- Specific absorbed fraction (1 revision)
- ICRP Publication 82 (1 revision)
- Surface contamination (1 revision)
- Excess absolute risk (1 revision)
- Exposure pathway (1 revision)
- Translocation (1 revision)
- Multistage carcinogenesis model (1 revision)
- Functional subunits (1 revision)
- Activity median aerodynamic diameter (1 revision)
- Ground-level enhancement (1 revision)
- Phantom (1 revision)
- ICRP Publication 101a (1 revision)
- ICRP Publication 114 (1 revision)
- ICRP Publication 129 (1 revision)
- ICRP Publication 143 (1 revision)
- Compartment (environmental) (1 revision)
- Ras (1 revision)
- ICRP Publication 18 (1 revision)
- Cross section (1 revision)
- Reference phantom (1 revision)
- ICRP Publication 30 (Part 2) (1 revision)
- ICRP Publication 91 (1 revision)
- ICRP Publication 4 (1 revision)
- ICRP Publication 54 (1 revision)
- Slice (1 revision)
- ICRP Publication 69 (1 revision)
- ICRP Publication 83 (1 revision)
- Threshold level (1 revision)
- Organ at risk (1 revision)
- Homologous recombination (1 revision)
- Authorised discharge (1 revision)
- ICRP Publication 101b (1 revision)
- Principles of protection (1 revision)
- ICRP Publication 115 (1 revision)
- Radiation-induced second cancer (1 revision)
- ICRP Publication 13 (1 revision)
- Clinical audit (1 revision)
- ICRP Publication 144 (1 revision)
- Rb (1 revision)
- ICRP Publication 19 (1 revision)
- Reference value (1 revision)
- ICRP Publication 30 (Part 3) (1 revision)
- Derived consideration reference level (1 revision)
- ICRP Publication 92 (1 revision)
- ICRP Publication 40 (1 revision)
- ICRP Publication 55 (1 revision)
- Dose conversion convention (1 revision)
- Informed consent (1 revision)
- ICRP Publication 7 (1 revision)
- Spongiosa (1 revision)
- ICRP Publication 84 (1 revision)
- Exclusion (1 revision)
- Marrow cellularity (1 revision)
- Multitarget equation (1 revision)
- Acute exposure (1 revision)
- Allometry (1 revision)
- Pilomatricoma (1 revision)
- ICRP Publication 102 (1 revision)
- ICRP Publication 116 (1 revision)
- Radiation-induced secondary malignancy (1 revision)
- ICRP Publication 130 (1 revision)
- Radiological attack (1 revision)
- ICRP Publication 145 (1 revision)
- Reactive oxygen species (1 revision)
- ICRP Publication 2 (1 revision)
- Reference worker (1 revision)
- ICRP Publication 30 (Part 4) (1 revision)
- Derived investigation level (1 revision)
- ICRP Publication 93 (1 revision)
- ICRP Publication 41 (1 revision)
- Directional dose equivalent (1 revision)
- ICRU 4-element tissue (1 revision)
- ICRP Publication 56 (1 revision)
- Dose conversion factor (1 revision)
- ICRP Publication 70 (1 revision)
- Effect modifier (1 revision)
- ICRP Publication 85 (1 revision)
- Endosteum (1 revision)
- System of radiological protection (1 revision)
- Time-resolved computed tomography (1 revision)
- Mutation component (1 revision)
- Waste management (1 revision)
- Normal tissue complication probability (1 revision)
- Biological half-life (1 revision)
- ICRP Publication 117 (1 revision)
- ICRP Publication 131 (1 revision)
- Radiological controlled area (1 revision)
- ICRP Publication 146 (1 revision)
- Concentration ratio (1 revision)
- ICRP Publication 20 (1 revision)
- Referrer (1 revision)
- ICRP Publication 30 (Supplement A to Part 3) (1 revision)
- Derived limit (1 revision)
- ICRP Publication 94 (1 revision)
- ICRP Publication 42 (1 revision)
- ICRU sphere (1 revision)
- ICRP Publication 57 (1 revision)
- ICRP Publication 71 (1 revision)
- ICRP Publication 86 (1 revision)
- Treatment preparation in radiotherapy (1 revision)
- Notification value (1 revision)
- Other (systemic) tissues (1 revision)
- Human Alimentary Tract Model (1 revision)
- ICRP Publication 104 (1 revision)
- Biomarker (1 revision)
- ICRP Publication 132 (1 revision)
- Clonogenic surviving fraction (1 revision)
- ICRP Publication 147 (1 revision)
- Cone beam computed tomography (1 revision)
- ICRP Publication 21 (1 revision)
- Region (1 revision)
- Retrievability (2 revisions)
- Immune system (2 revisions)
- Institutional control (2 revisions)
- Stakeholder (2 revisions)
- Environmental radiation protection (2 revisions)
- Tachycardia (2 revisions)
- Exemption level (2 revisions)
- Tissue equivalent material (2 revisions)
- Myocardial stress test (2 revisions)
- Oversight (2 revisions)
- Projected dose (2 revisions)
- Co-expertise (2 revisions)
- Radionuclides of natural origin (2 revisions)
- Connective tissue (2 revisions)
- Recovery (cellular or tissue) (2 revisions)
- DRL process (2 revisions)
- Reversibility (2 revisions)
- In vivo radiobioassay (2 revisions)
- Solar particle event (2 revisions)
- Effective dose equivalent (2 revisions)
- Existing exposure situation (2 revisions)
- Gastroschisis (2 revisions)
- Worker (2 revisions)
- Nuclear track detectors (2 revisions)
- Angiogenesis (2 revisions)
- Hyperbaric oxygen (2 revisions)
- Bioturbation (2 revisions)
- Cardioverter-defibrillator (2 revisions)
- Radiation safety officer (2 revisions)
- Radioresponsiveness (2 revisions)
- Consequential late effects (2 revisions)
- Recovery responder (2 revisions)
- Rehabilitation of living conditions (2 revisions)
- Right to know (2 revisions)
- Incidence (2 revisions)
- Solar wind (2 revisions)
- Epithelium (2 revisions)
- Target tissue (2 revisions)
- Measuring and Reducing Radon Levels in your Home (2 revisions)
- Acceptance test (2 revisions)
- Gastrulation (2 revisions)
- Working level (2 revisions)
- OLINDA/EXM (2 revisions)
- Habitual mouth breather (2 revisions)
- Annihilation photons (2 revisions)
- Particle radiance (2 revisions)
- Hyperfractionation (2 revisions)
- Bone marrow (2 revisions)
- Protection strategy (2 revisions)
- Radiation source (2 revisions)
- Cohort study (2 revisions)
- Radiosensitiser (2 revisions)
- DRL value (2 revisions)
- Rigidity (2 revisions)
- Dose-length product (2 revisions)
- Security (2 revisions)
- Incident (2 revisions)
- Intermediate level waste (2 revisions)
- Stenosis (2 revisions)
- Equieffective dose (2 revisions)
- Local DRL (2 revisions)
- Expanded and aligned radiation field (2 revisions)
- Tolerability (2 revisions)
- Medical exposure (2 revisions)
- Naturally occurring radioactive material (2 revisions)
- Adventitious (2 revisions)
- Working level month (2 revisions)
- Habitual nose breather (2 revisions)
- Hypertrophic cardiomyopathy (2 revisions)
- Background dose (rate) (2 revisions)
- Radiosensitivity, cellular (2 revisions)
- Containment (2 revisions)
- Detriment (2 revisions)
- Dose-rate effect (2 revisions)
- Inclusiveness (2 revisions)
- Source-related (2 revisions)
- Internal conversion electron (2 revisions)
- Electron-capture decay (2 revisions)
- LD 50/30 (2 revisions)
- Telangiectasia (2 revisions)
- Member of the public (2 revisions)
- Fluoroscopically or computed tomography guided interventions (2 revisions)
- Unattached fraction (2 revisions)
- Necrosis (2 revisions)
- Patient entrance reference point (2 revisions)
- Hypoplasia (2 revisions)
- Backscatter detection system (2 revisions)
- Potential recoverability correction factor (2 revisions)
- Bradycardia (2 revisions)
- Protective action guide (2 revisions)
- Radiation worker (2 revisions)
- Decay constant (2 revisions)
- Self-help protection (2 revisions)
- Individual-related (2 revisions)
- Dose of record Hp (10) (2 revisions)
- Electrophysiology (2 revisions)
- Storage (2 revisions)
- Track structure (2 revisions)
- Mendelian diseases (2 revisions)
- Accreditation (2 revisions)
- Neurological syndrome (2 revisions)
- Genomic integrity (2 revisions)
- Occupational exposure (2 revisions)
- Hazard (2 revisions)
- Peak skin dose (2 revisions)
- Bragg peak (2 revisions)
- Radioactive dispersion device (2 revisions)
- Radon: Units of Measure (2 revisions)
- Coronary heart disease (2 revisions)
- Reference air kerma (2 revisions)
- Decommissioning (2 revisions)
- ICRP Task Groups on Radiological Protection in Healthcare (2 revisions)
- Dose-threshold (2 revisions)
- Individual decontamination (2 revisions)
- Subcutaneous tissue (2 revisions)
- Low dose rate (2 revisions)
- Transfer compartment (2 revisions)
- Mitigation (2 revisions)
- Fractional absorption in the gastrointestinal tract (2 revisions)
- Action Level (2 revisions)
- Upper reference levels (2 revisions)
- Neurovascular syndrome (2 revisions)
- Health Surveillance (2 revisions)
- Pelagic (2 revisions)
- Basal cell (2 revisions)
- Practical radiological protection culture (2 revisions)
- Branching fraction (2 revisions)
- Chronic exposure (2 revisions)
- Radioactive source (2 revisions)
- Colony (2 revisions)
- Cosmic Radiation in Aviation (2 revisions)
- Decontamination (2 revisions)
- Relocation (2 revisions)
- Diastasis (2 revisions)
- Risk coefficient (2 revisions)
- Individual monitoring (2 revisions)
- Dose per unit intake coefficient (2 revisions)
- Source term (2 revisions)
- Emergency (2 revisions)
- Latent time/period or latency interval (2 revisions)
- Low level waste (2 revisions)
- Exposure, external or internal (2 revisions)
- Graft vs host disease (2 revisions)
- Air-kerma, incident (2 revisions)
- Heliosphere (2 revisions)
- Qualified expert (2 revisions)
- Class SR-0 gases (2 revisions)
- Radioactive substance (2 revisions)
- Reference biokinetic model (2 revisions)
- Decontamination factor (2 revisions)
- Remedial action (2 revisions)
- ICRPædia Guide to Dose Coefficients (2 revisions)
- Dose rate (2 revisions)
- Intervention Level (2 revisions)
- Emergency exposure situation (2 revisions)
- Substantial radiation dose level (2 revisions)
- Erythropoietin (2 revisions)
- Exposure (in the context of inhalation) (2 revisions)
- Transfer rate (2 revisions)
- Multi-detector computed tomography (2 revisions)
- Fractionation and dose delivery patterns (2 revisions)
- Percutaneous coronary intervention (2 revisions)
- Prevailing circumstances (2 revisions)
- Broad beam therapy irradiation technique (2 revisions)
- Class SR-1 gases (2 revisions)
- Committed effective dose (2 revisions)
- Radon Recommendations for Authorities (2 revisions)
- Cost-benefit analysis (2 revisions)
- Reference individual (2 revisions)
- Remediation (2 revisions)
- Dichotomous (2 revisions)
- Risk of Exposure to Radon (2 revisions)
- Dose rate effectiveness factor (2 revisions)
- South Atlantic anomaly (2 revisions)
- Interventional procedure (2 revisions)
- Emergency plan (2 revisions)
- Ethics (2 revisions)
- Lymphatic system (2 revisions)
- ALARA (2 revisions)
- Transforming growth factor (2 revisions)
- Hierarchical tissues (2 revisions)
- Area monitoring (2 revisions)
- Pericarditis (2 revisions)
- Benthic (2 revisions)
- Principle of application of dose limits (2 revisions)
- Bronchial region (2 revisions)
- Class SR-2 gases (2 revisions)
- Radioactivity (2 revisions)
- Committed equivalent dose (2 revisions)
- Radon Recommendations for Workplaces (2 revisions)
- Reference level (2 revisions)
- Deontological Ethics (2 revisions)
- Repopulation (2 revisions)
- Differentiation (2 revisions)
- Routine monitoring (2 revisions)
- ICRPædia Guide to Radon (2 revisions)
- Special (non-routine) monitoring (2 revisions)
- Lifetime risk (2 revisions)
- Macrophage colony stimulating factor (2 revisions)
- Multiplicative risk projection model (2 revisions)
- Activity (2 revisions)
- High level waste (2 revisions)
- Clearance (2 revisions)
- Representative organism (non-human biota) (2 revisions)
- ICRPædia Guide to the Basics of Ionising Radiation (2 revisions)
- Dose constraint (2 revisions)
- Early normal tissue responses (2 revisions)
- Threshold dose for tissue reactions (2 revisions)
- Magnetosphere (2 revisions)
- Beta-minus decay (2 revisions)
- Clearance level (2 revisions)
- Radiographer (2 revisions)
- Representative person (2 revisions)
- Safety (2 revisions)
- Dose conversion coefficient (2 revisions)
- Edema (2 revisions)
